Panel Discussion | Thrombus Management and Anticoagulation

Sunday, March 9, 2025

4:06 PM – 4:25 PM ET

Panel Moderator(s)

Dominick J. Angiolillo, MD, PhD, FSCAI

Professor of Medicine
University of Florida College of Medicine - Jacksonville
Jacksonville, Florida, United States

Disclosure(s): No financial relationships to disclose
Usman Baber, MD, MS

Professor of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States

Disclosure information not submitted.
David Cox, MD, MSCAI

Interventional Cardiologist
Sanger HVI Charlotte NC
Charlotte, North Carolina, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

SA

Surendra Avula, MD, FACC

Director, Cardiac Cthaetrization laboratories, Palos North Western Medical center Clinical Assocaite professor of medicine /Cardiology. University of illinois
Advocate Christ medical center/ Palos North Western Medical center
Orland park, Illinois, United States

Disclosure information not submitted.
F. Aaysha Cader, MD MRCP MSc (Oxon)

Cardiology Registrar
Kettering General Hospital, UK
Kettering, England, United Kingdom

Disclosure(s): No financial relationships to disclose
Marc Cohen, MD

Chair of Medicine
Newark Beth Israel Med Ctr
Philadelphia, Pennsylvania, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Daiichi Sankyo, Boeringer Ingelheim , Sanofi, AstraZeneca , Chiesi, Bracco, Amgen, Novo Nordisk, Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
George Dangas, MD, MACC, MSCAI

PROFESSOR OF CARDIOLOGY
The Mount Sinai Hospital
New York, New York, United States

Disclosure(s): No financial relationships to disclose
C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
Paul A. Gurbel, MD, FSCAI

Director
Sinai Center for Thrombosis Research and Drug Development
Baltimore, Maryland, United States

Disclosure information not submitted.
Adnan Kastrati, MD

Senior Consultant, Head of Catheterization Laboratory
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany

Disclosure(s): No financial relationships to disclose
Gregg W. Stone, MD, FACC, MSCAI

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)

Disclosure(s):

Dominick J. Angiolillo, MD, PhD, FSCAI: No financial relationships to disclose

David Cox, MD, MSCAI: No financial relationships to disclose

F. Aaysha Cader, MD MRCP MSc (Oxon): No financial relationships to disclose

Marc Cohen, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Daiichi Sankyo, Boeringer Ingelheim , Sanofi, AstraZeneca , Chiesi, Bracco, Amgen, Novo Nordisk, Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

George Dangas, MD, MACC, MSCAI: No financial relationships to disclose

Adnan Kastrati, MD: No financial relationships to disclose

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)